Skip to main content
Premium Trial:

Request an Annual Quote

Nature Too Backlogged to Publish Krebs' Paper in 1937

In March 1937, Hans Krebs and his colleague conducted an experiment observing the metabolic rate decline of the minced breast of a freshly killed pigeon suspended in solution. According to an article in The Scientist, by adding a salt of citric acid, they found they could keep the tissue "alive" for three times as long, and additional experiments showed the cyclical nature of the pathway which regenerates citric acid with each cycle and releases ATP. But alas, when Krebs submitted his paper to Nature, he was told that the journal had a "backlog of 'letters'" and couldn't publish it without "significant delay." But in 1953, writes The Scientist's Brendan Borrell, Krebs was more than vindicated when he won the Nobel Prize in Physiology or Medicine for discovering this citric acid cycle — the cellular pathway that converts carbohydrates, fats and proteins into energy — named the "Krebs cycle" in his honor. It took Nature a few more years to realize its mistake. In 1988, seven years after Krebs had died, an anonymous editor published a letter in the journal calling the rejection an "egregious error."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.